
Results of UK phase 3 clinical trial for Novavax COVID-19 vaccine published
Novavax have announced the publication of results from the final analysis of its Phase 3 clinical trial of its COVID-19 vaccine (NVX-CoV2373), conducted in the UK and led by researchers at the Vaccine Institute at St George's.
Jul 2, 2021
0
2